A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion

NCT04740905 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

553

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Edema
Branch Retinal Vein Occlusion

Interventions

DRUG: Faricimab
DRUG: Aflibercept
PROCEDURE: Sham Procedure

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]